GPX4 and neoplasm: ART significantly reduced GSH content and GPX4 expression in sunitinib-resistant KTCTL-26 renal cell carcinoma cells to induce ferroptosis, thus exhibiting more potent anti-tumor effects (Markowitsch et al., 2020).